Related Experiment Video
Updated: Jan 20, 2026

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
Novel O/W nanoemulsions for nasal administration: Structural hints in the selection of performing vehicles with
Emanuela Di Cola1, Laura Cantu'2, Paola Brocca2
1Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, via fratelli Cervi 93, 20900 Segrate (Mi), Italy; Institute Laue-Langevin (ILL), 71 avenue des Martyrs, CS 20156, 38042 Grenoble Cedex 9, France.
Abstract:
We propose novel oil-in-water nanoemulsions (O/W NEs) including PEGylated surfactants and chitosan, showing good biocompatibility and optimization for nasal administration of drugs or vaccines. The transmucosal route has been shown to be ideal for a fast and efficient absorption and represents a viable alternative when the oral administration is problematic. The critical structural features in view of optimal encapsulation and transmucosal delivery were assessed by characterizing the NEs with complementary scattering techniques, i.e. dynamic light scattering (DLS), small angle X-ray (SAXS) and neutron scattering (SANS). Combined results allowed for selecting the formulations with the best suited structural properties and in addition establishing their propensity to enter the mucus barrier. To this scope, mucin was used as a model system and the effect of adding chitosan to the NEs, as adjuvant, was investigated. Remarkably, the presence of chitosan had a positive impact on the diffusion of the NE particles through the mucin matrix. We can infer that chitosan-mucin interaction induces density inhomogeneity and an increase in the pore size within the gel matrix that enhances the PEGylated NEs mobility. The coupling of mucoadhesive and mucopenetrating agents is shown to be a promising strategy for innovative transmucosal delivery systems.
Related Concept Videos
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
14:57Structural Design and Manufacturing of a Cruiser Class Solar Vehicle
10:42A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
01:50Preparation of a Nanoemulsion Adjuvant Vaccine
07:10Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
06:02Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses

